Beijing has moved to cut prices of drugs and improve their efficacy and safety. Here a woman works at the pharmacy of a state-owned hospital in a town in Hebei province, China, in this photo taken in 2008.

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

  • New policy environment demanding cheaper drugs adds pressure to innovate
  • China’s hospital drugs market was US$118 billion last year
Topic |   Pharmaceuticals

TOP PICKS

Beijing has moved to cut prices of drugs and improve their efficacy and safety. Here a woman works at the pharmacy of a state-owned hospital in a town in Hebei province, China, in this photo taken in 2008.
READ FULL ARTICLE